Roux-en-Y gastric bypass rapidly reversed obesity-induced endothelial dysfunction and restored HDL endothelium-protective properties via a GLP-1-mediated mechanism at 8 days.
Does Roux-en-Y gastric bypass improve endothelial and HDL function in obesity via a GLP-1-dependent mechanism?
Roux-en-Y gastric bypass rapidly reverses obesity-induced endothelial and HDL dysfunction through a weight-independent, GLP-1-mediated mechanism.
BACKGROUND: Roux-en-Y gastric bypass (RYGB) reduces body weight and cardiovascular mortality in morbidly obese patients. Glucagon-like peptide-1 (GLP-1) seems to mediate the metabolic benefits of RYGB partly in a weight loss-independent manner. The present study investigated in rats and patients whether obesity-induced endothelial and high-density lipoprotein (HDL) dysfunction is rapidly improved after RYGB via a GLP-1-dependent mechanism. METHODS AND RESULTS: Eight days after RYGB in diet-induced obese rats, higher plasma levels of bile acids and GLP-1 were associated with improved endothelium-dependent relaxation compared with sham-operated controls fed ad libitum and sham-operated rats that were weight matched to those undergoing RYGB. Compared with the sham-operated rats, RYGB improved nitric oxide (NO) bioavailability resulting from higher endothelial Akt/NO synthase activation, reduced c-Jun amino terminal kinase phosphorylation, and decreased oxidative stress. The protective effects of RYGB were prevented by the GLP-1 receptor antagonist exendin9-39 (10 μg·kg(-1)·h(-1)). Furthermore, in patients and rats, RYGB rapidly reversed HDL dysfunction and restored the endothelium-protective properties of the lipoprotein, including endothelial NO synthase activation, NO production, and anti-inflammatory, antiapoptotic, and antioxidant effects. Finally, RYGB restored HDL-mediated cholesterol efflux capacity. To demonstrate the role of increased GLP-1 signaling, sham-operated control rats were treated for 8 days with the GLP-1 analog liraglutide (0.2 mg/kg twice daily), which restored NO bioavailability and improved endothelium-dependent relaxations and HDL endothelium-protective properties, mimicking the effects of RYGB. CONCLUSIONS: RYGB rapidly reverses obesity-induced endothelial dysfunction and restores the endothelium-protective properties of HDL via a GLP-1-mediated mechanism. The present translational findings in rats and patients unmask novel, weight-independent mechanisms of cardiovascular protection in morbid obesity.
Osto et al. (Thu,) conducted a other in Morbid obesity. Roux-en-Y gastric bypass (RYGB) vs. Sham surgery (in rats) was evaluated on Endothelial and high-density lipoprotein (HDL) function. Roux-en-Y gastric bypass rapidly reversed obesity-induced endothelial dysfunction and restored HDL endothelium-protective properties via a GLP-1-mediated mechanism at 8 days.